Enhancing tumor-specific T-cell immunity by inhibiting programmed death ligand 1 (PD-L1)–programmed death 1 (PD-1) signaling has shown promise in the treatment of extensive-stage small-cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback